Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation

We compared plasma levels of biomarkers of inflammation (CRP) and oxidation (oxLDL), determined at study inclusion in lone atrial fibrillation (LAF) patients (48.6±11.5 years; 74.0% men) and sinus rhythm controls (49.7±9.3 years; 72.7% men, P>0.05), and investigated the association of baseline CR...

Full description

Saved in:
Bibliographic Details
Main Authors: Marija M. Polovina, Miodrag C. Ostojic, Tatjana S. Potpara
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/653026
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551652983308288
author Marija M. Polovina
Miodrag C. Ostojic
Tatjana S. Potpara
author_facet Marija M. Polovina
Miodrag C. Ostojic
Tatjana S. Potpara
author_sort Marija M. Polovina
collection DOAJ
description We compared plasma levels of biomarkers of inflammation (CRP) and oxidation (oxLDL), determined at study inclusion in lone atrial fibrillation (LAF) patients (48.6±11.5 years; 74.0% men) and sinus rhythm controls (49.7±9.3 years; 72.7% men, P>0.05), and investigated the association of baseline CRP and oxLDL levels with the risk for vascular disease (VD) development (hypertension, cerebrovascular disease, coronary/peripheral artery disease, and pulmonary embolism) during prospective follow-up. Baseline CRP (1.2 [0.7–1.9] mg/L versus 1.1 [0.7–1.6] mg/L) and oxLDL levels (66.3±21.2 U/L versus 57.1±14.6 U/L) were higher in LAF patients (both P<0.05). Following a median of 36 months, incident VD occurred in 14 (28.0%) LAF patients, all of whom developed arterial hypertension, and in 5 (11.4%) controls (hypertension, n=4; coronary artery disease, n=1), P<0.05. LAF patients developed VD more frequently and at a younger age. Both CRP (HR, 2.54; 95% CI, 1.26–5.12; P=0.009) and oxLDL (HR, 2.24; 95% CI, 1.14–4.40; P=0.019) were multivariate predictors of incident hypertension in LAF patients, but not in the controls. Further research should clarify clinical relevance of investigated biomarkers for risk stratification and treatment of LAF patients.
format Article
id doaj-art-23efddcef26b4dbfa01449cea57ebdd1
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-23efddcef26b4dbfa01449cea57ebdd12025-02-03T06:00:53ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/653026653026Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial FibrillationMarija M. Polovina0Miodrag C. Ostojic1Tatjana S. Potpara2Cardiology Clinic, Clinical Center of Serbia, Visegradska 26, 11000 Belgrade, SerbiaSchool of Medicine, Belgrade University, Dr. Subotica 8, 11000 Belgrade, SerbiaCardiology Clinic, Clinical Center of Serbia, Visegradska 26, 11000 Belgrade, SerbiaWe compared plasma levels of biomarkers of inflammation (CRP) and oxidation (oxLDL), determined at study inclusion in lone atrial fibrillation (LAF) patients (48.6±11.5 years; 74.0% men) and sinus rhythm controls (49.7±9.3 years; 72.7% men, P>0.05), and investigated the association of baseline CRP and oxLDL levels with the risk for vascular disease (VD) development (hypertension, cerebrovascular disease, coronary/peripheral artery disease, and pulmonary embolism) during prospective follow-up. Baseline CRP (1.2 [0.7–1.9] mg/L versus 1.1 [0.7–1.6] mg/L) and oxLDL levels (66.3±21.2 U/L versus 57.1±14.6 U/L) were higher in LAF patients (both P<0.05). Following a median of 36 months, incident VD occurred in 14 (28.0%) LAF patients, all of whom developed arterial hypertension, and in 5 (11.4%) controls (hypertension, n=4; coronary artery disease, n=1), P<0.05. LAF patients developed VD more frequently and at a younger age. Both CRP (HR, 2.54; 95% CI, 1.26–5.12; P=0.009) and oxLDL (HR, 2.24; 95% CI, 1.14–4.40; P=0.019) were multivariate predictors of incident hypertension in LAF patients, but not in the controls. Further research should clarify clinical relevance of investigated biomarkers for risk stratification and treatment of LAF patients.http://dx.doi.org/10.1155/2015/653026
spellingShingle Marija M. Polovina
Miodrag C. Ostojic
Tatjana S. Potpara
Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
Mediators of Inflammation
title Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
title_full Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
title_fullStr Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
title_full_unstemmed Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
title_short Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation
title_sort relation of biomarkers of inflammation and oxidative stress with hypertension occurrence in lone atrial fibrillation
url http://dx.doi.org/10.1155/2015/653026
work_keys_str_mv AT marijampolovina relationofbiomarkersofinflammationandoxidativestresswithhypertensionoccurrenceinloneatrialfibrillation
AT miodragcostojic relationofbiomarkersofinflammationandoxidativestresswithhypertensionoccurrenceinloneatrialfibrillation
AT tatjanaspotpara relationofbiomarkersofinflammationandoxidativestresswithhypertensionoccurrenceinloneatrialfibrillation